SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001209191-18-063964
Filing Date
2018-12-21
Accepted
2018-12-21 17:16:35
Documents
1
Period of Report
2018-12-20

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 3631
  Complete submission text file 0001209191-18-063964.txt   5752
Mailing Address 50 NORTHERN AVENUE BOSTON MA 02210
Business Address 50 NORTHERN AVENUE BOSTON MA 02210 6173416393
VERTEX PHARMACEUTICALS INC / MA (Reporting) CIK: 0000875320 (see all company filings)

State of Incorp.: MA | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 181250495
SIC: 2834 Pharmaceutical Preparations

Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Issuer) CIK: 0001674416 (see all company filings)

IRS No.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address 2 KINGDOM STREET, 9TH FLOOR LONDON X0 W2 6BD
Business Address 2 KINGDOM STREET, 9TH FLOOR LONDON X0 W2 6BD 617-341-6100
Vertex Pharmaceuticals (Europe) Ltd (Reporting) CIK: 0001761216 (see all company filings)

State of Incorp.: X0 | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-37923 | Film No.: 181250496